Biomedical materials firm Haohai Healthcare put up $14m for Recros Medica, which is commercialising a new plastic surgery technique for improving the smoothness of skin.
Absorbable biomedical materials producer Haohai Healthcare has supplied $14m of series A capital for Recros Medica, the US-based developer of a fractional plastic surgery technique.
Founded in 2014, Recros Medica has developed a minimally-invasive plastic surgery operation that relies on a technique called rotational fractional resectioning to improve the smoothness of skin.
Proceeds from the round will progress the product under the brand name of Nuvellus Focal Contouring System, and fund a clinical study to support regulatory approval in the…
